CROs: pharma partners or rival, asks report?
This article was originally published in Scrip
Executive Summary
Contract research organisations (CRO) are gaining the right skills to become direct competitors to their clients, the pharmaceutical and biotechnology business, as the level of drug discovery and development outsourcing increases in the future.